Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Total Biopharma Alliance Revenues by Year
Total Biopharma Alliance Revenues (cross-portfolio summary) — International operational (constant-currency) YoY (%) (%)
Pfizer Total Biopharma Alliance Revenues: 11.0% in FY2025, up 18.0 pts from a year earlier.
Where the FY2025 figure comes from
“|| Total Alliance revenues included above | $ | 9,266 | $ | 8,388 | 10% | 10% | $ | 7,209 | $ | 6,575 | 10% | $ | 2,057 | $ | 1,813 | 13% | 11%”
Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
Reported in Form 8-K Revenue Tables.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Pfizer Total Biopharma Alliance Revenues (%), annual FY2017–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/alliance-rev-oper-intl
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.